Veena Vijayan

Developed critical thinking and advanced problem-solving skills in rigorous academic setting. Transitioning to new field, leveraging expertise in data analysis and experimental design. Aims to drive innovation and contribute to impactful projects in dynamic environment.

First author/ Co-first author

1. Thiruppathi J, Vijayan V , Hwang HS, Bang YJ, Loeurng V, Hong SH, Sundaram A, Park IK, Lee SE, Rhee JH. Thermoresistant flagellin-adjuvanted cancer vaccine combined with photothermal therapy synergizes with anti-PD-1 treatment. J Immunother Cancer. 2025

2. Jun, M., Vijayan, V. , Shin, S., Nam, H.Y., Song, D.,Choi, J.,Vasvani, S., Cho, S,K., Park IK., Seo, J., A bleomycin-mimicking manganese-porphyrin-conjugated mitochondria-targeting peptoid for cancer therapy. Bioorganics & Medicinal Chemistry. 2025

3. Thiruppathi, J., Vijayan,V .,Park IK.,Lee,S.H.,Rhee.J.H. Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better. Frontiers in Immunology.2024

4. Vijayan, V ., Sundaram, A., Vasukutty, A., Bardhan, R., Uthaman,S., Park IK. Tumor-targeting cell membrane-coated nanorings for magnetic-hyperthermia-induced tumor ablation. Biomaterials Science . 2023

5. Sun, E. G., Vijayan, V. , Park, M. R., Yoo, K. H., Cho, S. H., Bae, W. K., ... & Chung, I. J. (2023). Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-α–TAK1–MMP9 axis. Cell Death Discovery , 9(1), 122.

6. Seong, S., Vijayan, V. , Kim, J. H., Kim, K., Kim, I., Cherukula, K., ... & Kim, N. (2023). Nano-formulations for bone-specific delivery of siRNA for CrkII silencing-induced regulation of bone formation and resorption to maximize therapeutic potential for bone-related diseases. Biomaterials Science , 11(7), 2581-2589.

7. Vijayan V , Uthaman S, Park IK. Cell membrane-camouflaged nanoparticles: a promising biomimetic strategy for cancer theragnostics. Polymers . 2018 Sep;10(9):983.

8. Vijayan V , Mohapatra A, Uthaman S, Park IK. Recent advances in nanovaccines using biomimetic immunomodulatory materials. Pharmaceutics . 2019 Oct;11(10):534.

9. Vijayan V , Uthaman S, Park IK. Cell membrane coated nanoparticles: an emerging biomimetic nanoplatform for targeted bioimaging and therapy. Biomimetic Medical Materials (Book Chapter). 2018:45-59.

10. Vijayan V, Sundaram, A, Vasukutty, A., Bardhan, R., Uthaman,S., Park IK. Pyroptosis mediated cancer depletion by Immunotherapeutic Membrane proteolipid nano-frameworks (In- Preparation)

Co- author

1. Pillarisetti, S., Vijayan, V ., Rangasamy, J., Bardhan, R., Uthaman, S., & Park, I. K. (2023). A multi-stimuli responsive alginate nanogel for anticancer chemo-photodynamic therapy. Journal of Industrial and Engineering Chemistry , 123, 361-370.

2. Thomas, R. G., Kim, S., Nagareddy, R., Vijayan, V ., Pullickal, A. M., Yoon, M. S., ... & Jeong, Y. Y. (2023). Lipo-MGN nanoparticle hypoxia attenuation-mediated single-dose radiotherapy-and pH/ROS-responsive T1 contrast magnetic resonance imaging in hepatocellular carcinoma. Cancer Nanotechnology , 14(1), 53.

3. Zhang, W. J., Li, S., Vijayan, V., Lee, J. S., Park, S. S., Cui, X., ... & Ha, C. S. (2022). ROS-and pH-Responsive Polydopamine Functionalized Ti3C2Tx MXene-Based Nanoparticles as Drug Delivery Nanocarriers with High Antibacterial Activity. Nanomaterials , 12(24), 4392.

4. Revuri V, Cherukula K, Nafiujjaman M, Vijayan V , Jeong YY, Park IK, Lee YK. In situ oxygenic nanopods targeting tumor adaption to hypoxia potentiate image-guided photothermal therapy. ACS applied materials & interfaces . 2019 May 15;11(22):19782-92.

5. Rajendrakumar SK, Venu A, Revuri V, George Thomas R, Thirunavukkarasu GK, Zhang J, Vijayan V , Choi SY, Lee JY, Lee YK, Jeong YY. Hyaluronan-stabilized redox-sensitive nanoassembly for chemo-gene therapy and dual T1/T2 MR imaging in drug-resistant breast cancer cells. Molecular pharmaceutics . 2019 Mar 29;16(5):2226-34.

6. Cherukula K, Park MS, Sontyana AG, Mathew AP, Vijayan V , Bae WK, Park IK. Role of immunosuppressive microenvironment in acquiring immunotolerance post-photothermal therapy. Journal of Korean medical science . 2019 Nov 18;34(44).

7. Hwang HS, Cherukula K, Bang YJ, Vijayan V , Moon MJ, Thiruppathi J, Puth S, Jeong YY, Park IK, Lee SE, Rhee JH. Combination of Photodynamic Therapy and a Flagellin-Adjuvanted Cancer Vaccine Potentiated the Anti-PD-1-Mediated Melanoma Suppression. Cells. 2020 Nov;9(11):2432.

• The Outstanding Presentation Award- Combinatorial Tumor Immunotherapy Research Center 2019
• Best poster presentation – Tissue Engineering and Regenerative Medicine International Society, October 2022
• Best poster presentation – Hwasun Biomedical Workshop 2022
• Best poster presentation – The Korean Society for Biomaterials, 2019
• Best poster presentation – Hwasun Biomedical Workshop 2019